Table 1.
Patients' characteristics | Whole cohort | |
---|---|---|
N = 99 (%) | ||
General | ||
Mean age (years) | 64 | |
Male gender | 51 (52%) | |
Risk factor | Smoking | |
No | 10 (10%) | |
Cessation >3years | 40 (40%) | |
Current | 49 (49%) | |
Preexisting cardiovascular diseases | ||
Coronary artery disease | 14 (14%) | |
Other artery disease | 11 (11%) | |
Arrhythmia/Conduction abnormality | 13 (13%) | |
Heart failure | ||
LVEF <40% | 1 (1%) | |
LVEF 40–50% | 6(6%) | |
LVEF >50% | 8(8%) | |
Cardiovascular risk factors | ||
Age (male >50 years; female >60 years) | 80 (81%) | |
Diabetes mellitus | 19 (19%) | |
Dyslipidaemia | 32 (32%) | |
Hypertension | 18 (18%) | |
Primary cancer type | Adenocarcinoma | 65 (66%) |
Squamous cell carcinoma | 17 (17%) | |
Small cell lung cancer | 12 (12%) | |
Others | 5 (5%) | |
Pre-ICI biomarkers | Positive serum troponin before ICI | 6 (6%) |
Troponin (ng/l) | 13+/−21μ | |
BNP (pg/ml) | 44+/−41π | |
NT-pro-BNP (pg/ml) | 341+/−448Ω | |
CPK (UI/l) | 64+/−55† | |
Pre-ICI ECG | PR (ms) | 153+/−27‡ |
QRS (ms) | 94+/−21 | |
Pre-ICI TTE | LVEG (%) | 61%+/−6.5% |
Strain (%) | −18%+/−3.1% | |
S'VD (cm/s) | 13.6+/−2.66 |
Missing data :
= 8 (8%),
= 25 (25%),
= 14 (14%),
= 11 (11%),
=9 (9%), = 2 (2%), = 39 (39%), = 14 (14%)Patients concerned :
= 15 (15%).
ECG, electrocardiogram; ICI, Immune checkpoint inhibitors; TTE, Transthoracic echocardiogram; LVEG, Left ventricular ejection fraction.
Data were expressed as mean +/- standard deviation, as appropriate.